DK1131072T3 - Farmaceutisk kombinationspræparat i fast doseringsform med carvedilol og hydrochlorthiazid - Google Patents

Farmaceutisk kombinationspræparat i fast doseringsform med carvedilol og hydrochlorthiazid

Info

Publication number: DK1131072T3
Authority: DK; Denmark
Prior art keywords: carvedilol; hydrochlorothiazide; solid pharmaceutical; pharmaceutical combination; combination formulation
Prior art date: 1998-11-27

Application number

DK99957320T

Other languages

Danish (da)

English (en)

Inventor

Rudolf Heller

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-27

Filing date

1999-11-20

Publication date

2003-08-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8233041&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1131072(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-11-20 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2003-08-11 Application granted granted Critical

2003-08-11 Publication of DK1131072T3 publication Critical patent/DK1131072T3/da

Links

JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 title 1
NPAKNKYSJIDKMW-UHFFFAOYSA-N carvedilol Chemical compound COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=NC3=CC=C[CH]C3=C12 NPAKNKYSJIDKMW-UHFFFAOYSA-N 0.000 title 1
229960004195 carvedilol Drugs 0.000 title 1
238000009472 formulation Methods 0.000 title 1
229960002003 hydrochlorothiazide Drugs 0.000 title 1
239000000203 mixture Substances 0.000 title 1
239000007787 solid Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Cardiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

DK99957320T 1998-11-27 1999-11-20 Farmaceutisk kombinationspræparat i fast doseringsform med carvedilol og hydrochlorthiazid DK1131072T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP98122489		1998-11-27
PCT/EP1999/008972 WO2000032174A2 (en)	1998-11-27	1999-11-20	Pharmaceutical combination preparations of carvedilol and hydrochlorothiazide

Publications (1)

Publication Number	Publication Date
DK1131072T3 true DK1131072T3 (da)	2003-08-11

Family

ID=8233041

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99957320T DK1131072T3 (da)	1998-11-27	1999-11-20	Farmaceutisk kombinationspræparat i fast doseringsform med carvedilol og hydrochlorthiazid

Country Status (22)

Country	Link
US (3)	US6403579B1 (de)
EP (1)	EP1131072B1 (de)
JP (2)	JP2002531395A (de)
KR (1)	KR100421347B1 (de)
CN (1)	CN1184971C (de)
AR (1)	AR020287A1 (de)
AT (1)	ATE238056T1 (de)
AU (1)	AU765977B2 (de)
BR (1)	BR9915610A (de)
CA (1)	CA2352361C (de)
CO (1)	CO5011053A1 (de)
DE (1)	DE69907252T2 (de)
DK (1)	DK1131072T3 (de)
ES (1)	ES2195638T3 (de)
MY (1)	MY121831A (de)
PE (1)	PE20001302A1 (de)
PT (1)	PT1131072E (de)
TR (3)	TR200101470T2 (de)
TW (1)	TWI228414B (de)
UY (1)	UY25821A1 (de)
WO (1)	WO2000032174A2 (de)
ZA (1)	ZA200104280B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE20001302A1 (es) *	1998-11-27	2000-11-30	Hoffmann La Roche	Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida
WO2002065834A2 (en) *	2000-10-24	2002-08-29	Smithkline Beecham Corporation	Novel formulations of carvedilol
US20030070584A1 (en)	2001-05-15	2003-04-17	Cynthia Gulian	Dip coating compositions containing cellulose ethers
IN191028B (de) *	2001-05-17	2003-09-13	Sun Pharmaceutical Ind Ltd
US8309118B2 (en)	2001-09-28	2012-11-13	Mcneil-Ppc, Inc.	Film forming compositions containing sucralose
US8101209B2 (en)	2001-10-09	2012-01-24	Flamel Technologies	Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
JP2006500320A (ja) *	2002-04-30	2006-01-05	エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド	カルベジロール一クエン酸塩一水和物
MXPA04012923A (es) *	2002-06-27	2005-03-31	Sb Pharmco Inc	Sales de fosfato de carvedilol y/o solvatos de las mismas, composiciones correspondientes y/o metodos de tratamiento.
AU2003251627A1 (en)	2002-06-27	2004-01-19	Sb Pharmco Puerto Rico Inc.	Carvedilol hydrobromide
US7429619B2 (en)	2002-08-02	2008-09-30	Mcneil Consumer Healthcare	Polyacrylic film forming compositions
AU2003275953A1 (en)	2002-11-08	2004-06-07	Egalet A/S	Controlled release carvedilol compositions
EP1610767B1 (de)	2003-03-26	2011-01-19	Egalet A/S	Morphin-system mit kontrollierter freisetzung
WO2004094378A1 (en) *	2003-04-21	2004-11-04	Matrix Laboratories Ltd	Process for the preparation of carvedilol form-ii
WO2005030201A1 (en) *	2003-09-26	2005-04-07	Shuyi Zhang	Sustained release preparation containing hydrochlorothiazide
JP2007512372A (ja)	2003-11-25	2007-05-17	エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド	カルベジロール塩、対応する組成物、送達および／または治療方法
US20050169994A1 (en) *	2003-11-25	2005-08-04	Burke Matthew D.	Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
WO2005051322A2 (en) *	2003-11-25	2005-06-09	Sb Pharmco Puerto Rico Inc.	Controlled release pharmaceutical formulations comprising carvedilol, free based and its salts
AR047732A1 (es) *	2003-12-02	2006-02-15	Nicox Sa	Nitrooxiderivados de drogas antihipertensivas
NZ560232A (en) *	2005-02-25	2010-11-26	Hoffmann La Roche	Tablets with improved drug substance dispersibility
ES2523729T3 (es) *	2006-06-16	2014-12-01	Lek Pharmaceuticals D.D.	Composición farmacéutica que comprende hidroclorotiazida y telmisartán
GB0612540D0 (en) *	2006-06-23	2006-08-02	Novartis Ag	Galenical formulations of organic compounds
WO2008114276A1 (en) *	2007-03-16	2008-09-25	Lupin Limited	Novel oral controlled release composition of carvedilol
AU2008258596B2 (en)	2007-06-04	2013-02-14	Egalet Ltd	Controlled release pharmaceutical compositions for prolonged effect
NZ594207A (en)	2009-02-06	2013-03-28	Egalet Ltd	Immediate release composition resistant to abuse by intake of alcohol
WO2010149169A2 (en)	2009-06-24	2010-12-29	Egalet A/S	Controlled release formulations
AU2011226324B2 (en) *	2010-03-10	2015-09-24	Nogra Pharma Limited	Compositions for colon lavage and methods of making and using same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2815926A1 (de)	1978-04-13	1979-10-18	Boehringer Mannheim Gmbh	Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2643556B1 (fr) *	1989-02-27	1993-03-05	Sanofi Sa	Composition pharmaceutique a liberation prolongee d'acide valproique
FI20021701L (fi) *	1991-01-30	2002-09-24	Wellcome Found	Veteen dispergoituvia tabletteja
DE69222006T2 (de) *	1991-10-30	1998-01-22	Glaxo Group Ltd	Mehrschichtzusammensetzungen enthaltend Histamin- oder Serotonin- Antagonisten
TW483763B (en) *	1994-09-02	2002-04-21	Astra Ab	Pharmaceutical composition comprising of ramipril and dihydropyridine compound
US5760069A (en) *	1995-02-08	1998-06-02	Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1	Method of treatment for decreasing mortality resulting from congestive heart failure
FR2752162B1 (fr) *	1996-08-07	1998-11-06	Jouveinal Lab	Comprime de maleate de trimebutine pellicule
DE19637082A1 (de) *	1996-09-12	1998-03-19	Boehringer Mannheim Gmbh	Schnellzerfallende Pellets
PE20001302A1 (es) *	1998-11-27	2000-11-30	Hoffmann La Roche	Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida

1999
- 1999-11-19 PE PE1999001171A patent/PE20001302A1/es not_active Application Discontinuation
- 1999-11-20 TR TR2001/01470T patent/TR200101470T2/xx unknown
- 1999-11-20 BR BR9915610-5A patent/BR9915610A/pt not_active Application Discontinuation
- 1999-11-20 KR KR10-2001-7006570A patent/KR100421347B1/ko not_active Expired - Lifetime
- 1999-11-20 JP JP2000584870A patent/JP2002531395A/ja active Pending
- 1999-11-20 DE DE69907252T patent/DE69907252T2/de not_active Expired - Lifetime
- 1999-11-20 CN CNB998137561A patent/CN1184971C/zh not_active Expired - Lifetime
- 1999-11-20 ES ES99957320T patent/ES2195638T3/es not_active Expired - Lifetime
- 1999-11-20 EP EP99957320A patent/EP1131072B1/de not_active Expired - Lifetime
- 1999-11-20 AU AU15065/00A patent/AU765977B2/en not_active Expired
- 1999-11-20 CA CA002352361A patent/CA2352361C/en not_active Expired - Lifetime
- 1999-11-20 PT PT99957320T patent/PT1131072E/pt unknown
- 1999-11-20 DK DK99957320T patent/DK1131072T3/da active
- 1999-11-20 WO PCT/EP1999/008972 patent/WO2000032174A2/en not_active Ceased
- 1999-11-20 TR TR2002/00981T patent/TR200200981T2/xx unknown
- 1999-11-20 TR TR2002/00982T patent/TR200200982T2/xx unknown
- 1999-11-20 AT AT99957320T patent/ATE238056T1/de active IP Right Maintenance
- 1999-11-23 US US09/447,872 patent/US6403579B1/en not_active Expired - Lifetime
- 1999-11-24 AR ARP990105974A patent/AR020287A1/es unknown
- 1999-11-25 MY MYPI99005155A patent/MY121831A/en unknown
- 1999-11-25 CO CO99074400A patent/CO5011053A1/es unknown
- 1999-11-26 UY UY25821A patent/UY25821A1/es unknown
2000
- 2000-02-23 TW TW089103144A patent/TWI228414B/zh not_active IP Right Cessation
2001
- 2001-05-24 ZA ZA200104280A patent/ZA200104280B/xx unknown
- 2001-09-05 US US09/946,205 patent/US20020052367A1/en not_active Abandoned
2003
- 2003-10-24 US US10/693,243 patent/US20040087578A1/en not_active Abandoned
2006
- 2006-10-19 JP JP2006284476A patent/JP2007077160A/ja active Pending

Also Published As

Publication number	Publication date
CA2352361A1 (en)	2000-06-08
WO2000032174A2 (en)	2000-06-08
CN1184971C (zh)	2005-01-19
DE69907252D1 (de)	2003-05-28
KR20010080578A (ko)	2001-08-22
JP2007077160A (ja)	2007-03-29
MY121831A (en)	2006-02-28
TR200200981T2 (tr)	2002-06-21
CO5011053A1 (es)	2001-02-28
ZA200104280B (en)	2002-08-26
AR020287A1 (es)	2002-05-02
EP1131072B1 (de)	2003-04-23
AU765977B2 (en)	2003-10-09
EP1131072A2 (de)	2001-09-12
BR9915610A (pt)	2001-08-14
DE69907252T2 (de)	2004-01-29
ATE238056T1 (de)	2003-05-15
TR200200982T2 (tr)	2002-06-21
PT1131072E (pt)	2003-08-29
UY25821A1 (es)	2001-07-31
CA2352361C (en)	2007-01-02
CN1328460A (zh)	2001-12-26
KR100421347B1 (ko)	2004-03-06
US6403579B1 (en)	2002-06-11
TWI228414B (en)	2005-03-01
PE20001302A1 (es)	2000-11-30
ES2195638T3 (es)	2003-12-01
WO2000032174A3 (en)	2000-11-16
AU1506500A (en)	2000-06-19
US20040087578A1 (en)	2004-05-06
JP2002531395A (ja)	2002-09-24
TR200101470T2 (tr)	2001-11-21
US20020052367A1 (en)	2002-05-02

Publication	Publication Date	Title
DK1767206T3 (da)	2010-01-25	Faste orale doseringsformer indeholdende valsartan og hydrochlorhiazid
IS6385A (is)	2002-05-15	Ný notkun og nýjar N-asabísýkló-amíð afleiður
NO20004778D0 (no)	2000-09-25	Amidderivater og nociceptin antagonister
NO20015359D0 (no)	2001-11-02	Nye medikamentblandinger basert på anti-cholinergisk effektive forbindelser og <beta>-mimetika
DE69907252T2 (de)	2004-01-29	Pharmazeutische kombinationspräparate in fester form enthaltend carvedilol und hydrochlorothiazid
PT1210380E (pt)	2005-05-31	Materiais dobraveis para dispositivos oftalmicos e otorrinolaringologicos
EE04452B1 (et)	2005-04-15	Farmatseutiliselt aktiivne morfolinool ja selle kasutamine
DE60208351D1 (de)	2006-02-02	Glukopyranosyloxybenzylbenzolderivate und deren medizinische verwendung
DE60230591D1 (de)	2009-02-12	Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
DE60237580D1 (de)	2010-10-21	Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
DK1354888T3 (da)	2009-09-21	Glukopyranosyloxypyrazolderivater og anvendelse deraf i medikamenter
NO20002359L (no)	2000-07-05	Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene
NO20011157D0 (no)	2001-03-07	Benzenderivater og farmasøytisk anvendelse derav
EE05169B1 (et)	2009-06-15	Asendatud oksasolidinoonid ja nende kasutamine
PT1212317E (pt)	2005-02-28	Derivados de indole e sua utilizacao no tratamento de osteoporose entre outras aplicacoes
NO20014560D0 (no)	2001-09-19	Quinasoliner og terapautisk anvendelse derav
DE60032898D1 (de)	2007-02-22	Arylthiazolidindion- und aryloxazolidinderivate
DE69903143D1 (de)	2002-10-31	Chromanon und thiochromanon derivate
NO20004277L (no)	2000-09-11	Indolderivater og farmasøytiske sammensetninger omfattende det samme
NO20010487D0 (no)	2001-01-29	Disubstituert maleimidforbindelse og farmasöytisk anvendelse herav
DK1200095T3 (da)	2005-11-14	Lægemiddel med protektiv virkning mod oxidativ-toksiske og især mod cardiotoksiske
NO986174D0 (no)	1998-12-29	Triazinderivater og anvendelse derav
DK1025100T3 (da)	2002-05-06	3-substituerede tetrahydropyridopyrimidinonderivater, fremstilling og anvendelsen heraf
DE60024476D1 (de)	2006-01-05	Pedikulizide und veterinärmedizinische zusammensetzungen
IS2607B (is)	2010-04-15	Afleiður tryptamíns og hliðstæð efnasambönd ásamt lyfjaforskriftum þeirra